drugset / Trial / NCT01097902

Study of Experimental Models of Pain and Inflammation.

NCT01097902

Phase 1 Completed 15 enrolled Martin Angst
RandomizedCrossoverTriple-blindBasic science

Summary

The experimental pain model studied in this proposal show characteristics of an inflamed wound with a pro-inflammatory response. This study will help discover candidate genetic and/or proteomic pain biomarkers that could provide objective and mechanism based tests to diagnose, monitor or quantify pain. We also hope to determine the measurable effects of a known non-steroidal anti-inflammatory drug (NSAID) on biomarkers of pain and inflammation.

Timeline

Start
2010-02
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 800 mg Oral

Indications

No indication recorded.